DEBAR Act of 2021

Debarment Enforcement of Bad Actor Registrants Act of 2021 or the DEBAR Act of 2021 This bill authorizes the Drug Enforcement Administration (DEA) to bar an entity from registering to manufacture, distribute, or dispense controlled substances under certain circumstances. Specifically, the DEA may bar—temporarily or permanently—the registration of an entity that (1) meets or has met any condition for suspension or revocation of the registration, and (2) has a history of prior suspensions or revocations.

Debarment Enforcement of Bad Actor Registrants Act of 2021 or the DEBAR Act of 2021 This bill authorizes the Drug Enforcement Administration (DEA) to bar an entity from registering to manufacture, distribute, or dispense controlled substances under certain circumstances. Specifically, the DEA may bar—temporarily or permanently—the registration of an entity that (1) meets or has met any condition for suspension or revocation of the registration, and (2) has a history of prior suspensions or revocations.

Debarment Enforcement of Bad Actor Registrants Act of 2021 or the DEBAR Act of 2021 This bill authorizes the Drug Enforcement Administration (DEA) to bar an entity from registering to manufacture, distribute, or dispense controlled substances under certain circumstances. Specifically, the DEA may bar—temporarily or permanently—the registration of an entity that (1) meets or has met any condition for suspension or revocation of the registration, and (2) has a history of prior suspensions or revocations.

Debarment Enforcement of Bad Actor Registrants Act of 2021 or the DEBAR Act of 2021 This bill authorizes the Drug Enforcement Administration (DEA) to bar an entity from registering to manufacture, distribute, or dispense controlled substances under certain circumstances. Specifically, the DEA may bar—temporarily or permanently—the registration of an entity that (1) meets or has met any condition for suspension or revocation of the registration; and (2) is unfit to manufacture, distribute, or dispense a controlled substance.

Signed by President.

Signed by President.

Became Public Law No: 117-36.

Became Public Law No: 117-36.

Presented to President.

Presented to President.

Message on Senate action sent to the House.

Senate Committee on the Judiciary discharged by Unanimous Consent.

Senate Committee on the Judiciary discharged by Unanimous Consent.

Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S5111)

Passed Senate without amendment by Unanimous Consent. (consideration: CR S5111)

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Considered as unfinished business. (consideration: CR H1831-1832)

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 5 (Roll no. 112).(text: 04/14/2021 CR H1763)

On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 5 (Roll no. 112). (text: 04/14/2021 CR H1763)

Motion to reconsider laid on the table Agreed to without objection.

Mr. Pallone moved to suspend the rules and pass the bill, as amended.

Considered under suspension of the rules. (consideration: CR H1763-1764)

DEBATE - The House proceeded with forty minutes of debate on H.R. 1002.

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

Referred to the Subcommittee on Health.

Introduced in House

Introduced in House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.